Global RNA Modifying Agents Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 RNA Modifying Agents Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global RNA Modifying Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 N6-Methyladenosine (m6A) Antibody
  • 1.2.3 5-Methylcytosine (5-mC) Antibody
  • 1.2.4 Others
• 1.3 Market by Application
  • 1.3.1 Global RNA Modifying Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Gene Therapy
  • 1.3.3 Cancer Research
  • 1.3.4 Drug Development
  • 1.3.5 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global RNA Modifying Agents Revenue Estimates and Forecasts 2019-2030
• 2.2 Global RNA Modifying Agents Revenue by Region
  • 2.2.1 Global RNA Modifying Agents Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global RNA Modifying Agents Revenue by Region (2019-2024)
  • 2.2.3 Global RNA Modifying Agents Revenue by Region (2025-2030)
  • 2.2.4 Global RNA Modifying Agents Revenue Market Share by Region (2019-2030)
• 2.3 Global RNA Modifying Agents Sales Estimates and Forecasts 2019-2030
• 2.4 Global RNA Modifying Agents Sales by Region
  • 2.4.1 Global RNA Modifying Agents Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global RNA Modifying Agents Sales by Region (2019-2024)
  • 2.4.3 Global RNA Modifying Agents Sales by Region (2025-2030)
  • 2.4.4 Global RNA Modifying Agents Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global RNA Modifying Agents Sales by Manufacturers
  • 3.1.1 Global RNA Modifying Agents Sales by Manufacturers (2019-2024)
  • 3.1.2 Global RNA Modifying Agents Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Modifying Agents in 2023
• 3.2 Global RNA Modifying Agents Revenue by Manufacturers
  • 3.2.1 Global RNA Modifying Agents Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global RNA Modifying Agents Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by RNA Modifying Agents Revenue in 2023
• 3.3 Global Key Players of RNA Modifying Agents, Industry Ranking, 2021 VS 2022
• 3.4 Global RNA Modifying Agents Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global RNA Modifying Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of RNA Modifying Agents, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of RNA Modifying Agents, Product Offered and Application
• 3.8 Global Key Manufacturers of RNA Modifying Agents, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global RNA Modifying Agents Sales by Type
  • 4.1.1 Global RNA Modifying Agents Historical Sales by Type (2019-2024)
  • 4.1.2 Global RNA Modifying Agents Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global RNA Modifying Agents Sales Market Share by Type (2019-2030)
• 4.2 Global RNA Modifying Agents Revenue by Type
  • 4.2.1 Global RNA Modifying Agents Historical Revenue by Type (2019-2024)
  • 4.2.2 Global RNA Modifying Agents Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global RNA Modifying Agents Revenue Market Share by Type (2019-2030)
• 4.3 Global RNA Modifying Agents Price by Type
  • 4.3.1 Global RNA Modifying Agents Price by Type (2019-2024)
  • 4.3.2 Global RNA Modifying Agents Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global RNA Modifying Agents Sales by Application
  • 5.1.1 Global RNA Modifying Agents Historical Sales by Application (2019-2024)
  • 5.1.2 Global RNA Modifying Agents Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global RNA Modifying Agents Sales Market Share by Application (2019-2030)
• 5.2 Global RNA Modifying Agents Revenue by Application
  • 5.2.1 Global RNA Modifying Agents Historical Revenue by Application (2019-2024)
  • 5.2.2 Global RNA Modifying Agents Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global RNA Modifying Agents Revenue Market Share by Application (2019-2030)
• 5.3 Global RNA Modifying Agents Price by Application
  • 5.3.1 Global RNA Modifying Agents Price by Application (2019-2024)
  • 5.3.2 Global RNA Modifying Agents Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada RNA Modifying Agents Market Size by Type
  • 6.1.1 US & Canada RNA Modifying Agents Sales by Type (2019-2030)
  • 6.1.2 US & Canada RNA Modifying Agents Revenue by Type (2019-2030)
• 6.2 US & Canada RNA Modifying Agents Market Size by Application
  • 6.2.1 US & Canada RNA Modifying Agents Sales by Application (2019-2030)
  • 6.2.2 US & Canada RNA Modifying Agents Revenue by Application (2019-2030)
• 6.3 US & Canada RNA Modifying Agents Market Size by Country
  • 6.3.1 US & Canada RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada RNA Modifying Agents Revenue by Country (2019-2030)
  • 6.3.3 US & Canada RNA Modifying Agents Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe RNA Modifying Agents Market Size by Type
  • 7.1.1 Europe RNA Modifying Agents Sales by Type (2019-2030)
  • 7.1.2 Europe RNA Modifying Agents Revenue by Type (2019-2030)
• 7.2 Europe RNA Modifying Agents Market Size by Application
  • 7.2.1 Europe RNA Modifying Agents Sales by Application (2019-2030)
  • 7.2.2 Europe RNA Modifying Agents Revenue by Application (2019-2030)
• 7.3 Europe RNA Modifying Agents Market Size by Country
  • 7.3.1 Europe RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe RNA Modifying Agents Revenue by Country (2019-2030)
  • 7.3.3 Europe RNA Modifying Agents Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China RNA Modifying Agents Market Size by Type
  • 8.1.1 China RNA Modifying Agents Sales by Type (2019-2030)
  • 8.1.2 China RNA Modifying Agents Revenue by Type (2019-2030)
• 8.2 China RNA Modifying Agents Market Size by Application
  • 8.2.1 China RNA Modifying Agents Sales by Application (2019-2030)
  • 8.2.2 China RNA Modifying Agents Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia RNA Modifying Agents Market Size by Type
  • 9.1.1 Asia RNA Modifying Agents Sales by Type (2019-2030)
  • 9.1.2 Asia RNA Modifying Agents Revenue by Type (2019-2030)
• 9.2 Asia RNA Modifying Agents Market Size by Application
  • 9.2.1 Asia RNA Modifying Agents Sales by Application (2019-2030)
  • 9.2.2 Asia RNA Modifying Agents Revenue by Application (2019-2030)
• 9.3 Asia RNA Modifying Agents Market Size by Region
  • 9.3.1 Asia RNA Modifying Agents Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia RNA Modifying Agents Revenue by Region (2019-2030)
  • 9.3.3 Asia RNA Modifying Agents Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America RNA Modifying Agents Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America RNA Modifying Agents Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America RNA Modifying Agents Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America RNA Modifying Agents Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America RNA Modifying Agents Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America RNA Modifying Agents Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America RNA Modifying Agents Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America RNA Modifying Agents Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America RNA Modifying Agents Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America RNA Modifying Agents Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Active Motif
  • 11.1.1 Active Motif Company Information
  • 11.1.2 Active Motif Overview
  • 11.1.3 Active Motif RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Active Motif RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Active Motif Recent Developments
• 11.2 Epigentek
  • 11.2.1 Epigentek Company Information
  • 11.2.2 Epigentek Overview
  • 11.2.3 Epigentek RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Epigentek RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Epigentek Recent Developments
• 11.3 Thermo Fisher Scientific
  • 11.3.1 Thermo Fisher Scientific Company Information
  • 11.3.2 Thermo Fisher Scientific Overview
  • 11.3.3 Thermo Fisher Scientific RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Thermo Fisher Scientific RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Thermo Fisher Scientific Recent Developments
• 11.4 Merck
  • 11.4.1 Merck Company Information
  • 11.4.2 Merck Overview
  • 11.4.3 Merck RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Merck RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Merck Recent Developments
• 11.5 Gene Link
  • 11.5.1 Gene Link Company Information
  • 11.5.2 Gene Link Overview
  • 11.5.3 Gene Link RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Gene Link RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Gene Link Recent Developments
• 11.6 abcam
  • 11.6.1 abcam Company Information
  • 11.6.2 abcam Overview
  • 11.6.3 abcam RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 abcam RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 abcam Recent Developments
• 11.7 ABclonal
  • 11.7.1 ABclonal Company Information
  • 11.7.2 ABclonal Overview
  • 11.7.3 ABclonal RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 ABclonal RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 ABclonal Recent Developments
• 11.8 MyBioSource
  • 11.8.1 MyBioSource Company Information
  • 11.8.2 MyBioSource Overview
  • 11.8.3 MyBioSource RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 MyBioSource RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 MyBioSource Recent Developments
• 11.9 Beyotime
  • 11.9.1 Beyotime Company Information
  • 11.9.2 Beyotime Overview
  • 11.9.3 Beyotime RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Beyotime RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Beyotime Recent Developments
• 11.10 Hologic
  • 11.10.1 Hologic Company Information
  • 11.10.2 Hologic Overview
  • 11.10.3 Hologic RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Hologic RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Hologic Recent Developments
• 11.11 Synaptic Systems
  • 11.11.1 Synaptic Systems Company Information
  • 11.11.2 Synaptic Systems Overview
  • 11.11.3 Synaptic Systems RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Synaptic Systems RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Synaptic Systems Recent Developments
• 11.12 Novus Biologicals
  • 11.12.1 Novus Biologicals Company Information
  • 11.12.2 Novus Biologicals Overview
  • 11.12.3 Novus Biologicals RNA Modifying Agents Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Novus Biologicals RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Novus Biologicals Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 RNA Modifying Agents Industry Chain Analysis
• 12.2 RNA Modifying Agents Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 RNA Modifying Agents Production Mode & Process
• 12.4 RNA Modifying Agents Sales and Marketing
  • 12.4.1 RNA Modifying Agents Sales Channels
  • 12.4.2 RNA Modifying Agents Distributors
• 12.5 RNA Modifying Agents Customers

13 RNA Modifying Agents Market Dynamics

• 13.1 RNA Modifying Agents Industry Trends
• 13.2 RNA Modifying Agents Market Drivers
• 13.3 RNA Modifying Agents Market Challenges
• 13.4 RNA Modifying Agents Market Restraints

14 Key Findings in the Global RNA Modifying Agents Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global RNA Modifying Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of N6-Methyladenosine (m6A) Antibody

Table 3. Major Manufacturers of 5-Methylcytosine (5-mC) Antibody

Table 4. Major Manufacturers of Others

Table 5. Global RNA Modifying Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global RNA Modifying Agents Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global RNA Modifying Agents Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global RNA Modifying Agents Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global RNA Modifying Agents Revenue Market Share by Region (2019-2024)

Table 10. Global RNA Modifying Agents Revenue Market Share by Region (2025-2030)

Table 11. Global RNA Modifying Agents Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 12. Global RNA Modifying Agents Sales by Region (2019-2024) & (K Units)

Table 13. Global RNA Modifying Agents Sales by Region (2025-2030) & (K Units)

Table 14. Global RNA Modifying Agents Sales Market Share by Region (2019-2024)

Table 15. Global RNA Modifying Agents Sales Market Share by Region (2025-2030)

Table 16. Global RNA Modifying Agents Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global RNA Modifying Agents Sales Share by Manufacturers (2019-2024)

Table 18. Global RNA Modifying Agents Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global RNA Modifying Agents Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of RNA Modifying Agents, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. RNA Modifying Agents Price by Manufacturers (2019-2024) & (US$/Unit)

Table 22. Global RNA Modifying Agents Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global RNA Modifying Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Modifying Agents as of 2023)

Table 24. Global Key Manufacturers of RNA Modifying Agents, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of RNA Modifying Agents, Product Offered and Application

Table 26. Global Key Manufacturers of RNA Modifying Agents, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global RNA Modifying Agents Sales by Type (2019-2024) & (K Units)

Table 29. Global RNA Modifying Agents Sales by Type (2025-2030) & (K Units)

Table 30. Global RNA Modifying Agents Sales Share by Type (2019-2024)

Table 31. Global RNA Modifying Agents Sales Share by Type (2025-2030)

Table 32. Global RNA Modifying Agents Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global RNA Modifying Agents Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global RNA Modifying Agents Revenue Share by Type (2019-2024)

Table 35. Global RNA Modifying Agents Revenue Share by Type (2025-2030)

Table 36. RNA Modifying Agents Price by Type (2019-2024) & (US$/Unit)

Table 37. Global RNA Modifying Agents Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global RNA Modifying Agents Sales by Application (2019-2024) & (K Units)

Table 39. Global RNA Modifying Agents Sales by Application (2025-2030) & (K Units)

Table 40. Global RNA Modifying Agents Sales Share by Application (2019-2024)

Table 41. Global RNA Modifying Agents Sales Share by Application (2025-2030)

Table 42. Global RNA Modifying Agents Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global RNA Modifying Agents Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global RNA Modifying Agents Revenue Share by Application (2019-2024)

Table 45. Global RNA Modifying Agents Revenue Share by Application (2025-2030)

Table 46. RNA Modifying Agents Price by Application (2019-2024) & (US$/Unit)

Table 47. Global RNA Modifying Agents Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada RNA Modifying Agents Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada RNA Modifying Agents Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada RNA Modifying Agents Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada RNA Modifying Agents Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada RNA Modifying Agents Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada RNA Modifying Agents Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada RNA Modifying Agents Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada RNA Modifying Agents Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada RNA Modifying Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada RNA Modifying Agents Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada RNA Modifying Agents Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada RNA Modifying Agents Sales by Country (2025-2030) & (K Units)

Table 61. Europe RNA Modifying Agents Sales by Type (2019-2024) & (K Units)

Table 62. Europe RNA Modifying Agents Sales by Type (2025-2030) & (K Units)

Table 63. Europe RNA Modifying Agents Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe RNA Modifying Agents Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe RNA Modifying Agents Sales by Application (2019-2024) & (K Units)

Table 66. Europe RNA Modifying Agents Sales by Application (2025-2030) & (K Units)

Table 67. Europe RNA Modifying Agents Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe RNA Modifying Agents Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe RNA Modifying Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe RNA Modifying Agents Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe RNA Modifying Agents Sales by Country (2019-2024) & (K Units)

Table 73. Europe RNA Modifying Agents Sales by Country (2025-2030) & (K Units)

Table 74. China RNA Modifying Agents Sales by Type (2019-2024) & (K Units)

Table 75. China RNA Modifying Agents Sales by Type (2025-2030) & (K Units)

Table 76. China RNA Modifying Agents Revenue by Type (2019-2024) & (US$ Million)

Table 77. China RNA Modifying Agents Revenue by Type (2025-2030) & (US$ Million)

Table 78. China RNA Modifying Agents Sales by Application (2019-2024) & (K Units)

Table 79. China RNA Modifying Agents Sales by Application (2025-2030) & (K Units)

Table 80. China RNA Modifying Agents Revenue by Application (2019-2024) & (US$ Million)

Table 81. China RNA Modifying Agents Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia RNA Modifying Agents Sales by Type (2019-2024) & (K Units)

Table 83. Asia RNA Modifying Agents Sales by Type (2025-2030) & (K Units)

Table 84. Asia RNA Modifying Agents Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia RNA Modifying Agents Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia RNA Modifying Agents Sales by Application (2019-2024) & (K Units)

Table 87. Asia RNA Modifying Agents Sales by Application (2025-2030) & (K Units)

Table 88. Asia RNA Modifying Agents Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia RNA Modifying Agents Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia RNA Modifying Agents Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia RNA Modifying Agents Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia RNA Modifying Agents Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia RNA Modifying Agents Sales by Region (2019-2024) & (K Units)

Table 94. Asia RNA Modifying Agents Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America RNA Modifying Agents Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America RNA Modifying Agents Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America RNA Modifying Agents Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America RNA Modifying Agents Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America RNA Modifying Agents Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America RNA Modifying Agents Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America RNA Modifying Agents Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America RNA Modifying Agents Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America RNA Modifying Agents Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America RNA Modifying Agents Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America RNA Modifying Agents Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America RNA Modifying Agents Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America RNA Modifying Agents Sales by Country (2025-2030) & (K Units)

Table 108. Active Motif Company Information

Table 109. Active Motif Description and Major Businesses

Table 110. Active Motif RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. Active Motif RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Active Motif Recent Developments

Table 113. Epigentek Company Information

Table 114. Epigentek Description and Major Businesses

Table 115. Epigentek RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. Epigentek RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Epigentek Recent Developments

Table 118. Thermo Fisher Scientific Company Information

Table 119. Thermo Fisher Scientific Description and Major Businesses

Table 120. Thermo Fisher Scientific RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. Thermo Fisher Scientific RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Thermo Fisher Scientific Recent Developments

Table 123. Merck Company Information

Table 124. Merck Description and Major Businesses

Table 125. Merck RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. Merck RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Merck Recent Developments

Table 128. Gene Link Company Information

Table 129. Gene Link Description and Major Businesses

Table 130. Gene Link RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Gene Link RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Gene Link Recent Developments

Table 133. abcam Company Information

Table 134. abcam Description and Major Businesses

Table 135. abcam RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. abcam RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. abcam Recent Developments

Table 138. ABclonal Company Information

Table 139. ABclonal Description and Major Businesses

Table 140. ABclonal RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 141. ABclonal RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. ABclonal Recent Developments

Table 143. MyBioSource Company Information

Table 144. MyBioSource Description and Major Businesses

Table 145. MyBioSource RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 146. MyBioSource RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. MyBioSource Recent Developments

Table 148. Beyotime Company Information

Table 149. Beyotime Description and Major Businesses

Table 150. Beyotime RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 151. Beyotime RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Beyotime Recent Developments

Table 153. Hologic Company Information

Table 154. Hologic Description and Major Businesses

Table 155. Hologic RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 156. Hologic RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Hologic Recent Developments

Table 158. Synaptic Systems Company Information

Table 159. Synaptic Systems Description and Major Businesses

Table 160. Synaptic Systems RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 161. Synaptic Systems RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Synaptic Systems Recent Developments

Table 163. Novus Biologicals Company Information

Table 164. Novus Biologicals Description and Major Businesses

Table 165. Novus Biologicals RNA Modifying Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 166. Novus Biologicals RNA Modifying Agents Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Novus Biologicals Recent Developments

Table 168. Key Raw Materials Lists

Table 169. Raw Materials Key Suppliers Lists

Table 170. RNA Modifying Agents Distributors List

Table 171. RNA Modifying Agents Customers List

Table 172. RNA Modifying Agents Market Trends

Table 173. RNA Modifying Agents Market Drivers

Table 174. RNA Modifying Agents Market Challenges

Table 175. RNA Modifying Agents Market Restraints

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. RNA Modifying Agents Product Picture

Figure 2. Global RNA Modifying Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global RNA Modifying Agents Market Share by Type: 2023 & 2030

Figure 4. N6-Methyladenosine (m6A) Antibody Product Picture

Figure 5. 5-Methylcytosine (5-mC) Antibody Product Picture

Figure 6. Others Product Picture

Figure 7. Global RNA Modifying Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global RNA Modifying Agents Market Share by Application: 2023 & 2030

Figure 9. Gene Therapy

Figure 10. Cancer Research

Figure 11. Drug Development

Figure 12. Other

Figure 13. RNA Modifying Agents Report Years Considered

Figure 14. Global RNA Modifying Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 16. Global RNA Modifying Agents Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 17. Global RNA Modifying Agents Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global RNA Modifying Agents Revenue Market Share by Region (2019-2030)

Figure 19. Global RNA Modifying Agents Sales (2019-2030) & (K Units)

Figure 20. Global RNA Modifying Agents Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 21. Global RNA Modifying Agents Sales Market Share by Region (2019-2030)

Figure 22. US & Canada RNA Modifying Agents Sales YoY (2019-2030) & (K Units)

Figure 23. US & Canada RNA Modifying Agents Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Europe RNA Modifying Agents Sales YoY (2019-2030) & (K Units)

Figure 25. Europe RNA Modifying Agents Revenue YoY (2019-2030) & (US$ Million)

Figure 26. China RNA Modifying Agents Sales YoY (2019-2030) & (K Units)

Figure 27. China RNA Modifying Agents Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Asia (excluding China) RNA Modifying Agents Sales YoY (2019-2030) & (K Units)

Figure 29. Asia (excluding China) RNA Modifying Agents Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Middle East, Africa and Latin America RNA Modifying Agents Sales YoY (2019-2030) & (K Units)

Figure 31. Middle East, Africa and Latin America RNA Modifying Agents Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Global RNA Modifying Agents Sales Share by Manufacturers (2023)

Figure 33. The RNA Modifying Agents Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 34. Global RNA Modifying Agents Revenue Share by Manufacturers (2023)

Figure 35. The Top 5 and 10 Largest Manufacturers of RNA Modifying Agents in the World: Market Share by RNA Modifying Agents Revenue in 2023

Figure 36. Global RNA Modifying Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 37. Global RNA Modifying Agents Sales Market Share by Type (2019-2030)

Figure 38. Global RNA Modifying Agents Revenue Market Share by Type (2019-2030)

Figure 39. Global RNA Modifying Agents Sales Market Share by Application (2019-2030)

Figure 40. Global RNA Modifying Agents Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada RNA Modifying Agents Sales Market Share by Type (2019-2030)

Figure 42. US & Canada RNA Modifying Agents Revenue Market Share by Type (2019-2030)

Figure 43. US & Canada RNA Modifying Agents Sales Market Share by Application (2019-2030)

Figure 44. US & Canada RNA Modifying Agents Revenue Market Share by Application (2019-2030)

Figure 45. US & Canada RNA Modifying Agents Revenue Share by Country (2019-2030)

Figure 46. US & Canada RNA Modifying Agents Sales Share by Country (2019-2030)

Figure 47. US RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 48. Canada RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 49. Europe RNA Modifying Agents Sales Market Share by Type (2019-2030)

Figure 50. Europe RNA Modifying Agents Revenue Market Share by Type (2019-2030)

Figure 51. Europe RNA Modifying Agents Sales Market Share by Application (2019-2030)

Figure 52. Europe RNA Modifying Agents Revenue Market Share by Application (2019-2030)

Figure 53. Europe RNA Modifying Agents Revenue Share by Country (2019-2030)

Figure 54. Europe RNA Modifying Agents Sales Share by Country (2019-2030)

Figure 55. Germany RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 56. France RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 57. U.K. RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 58. Italy RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 59. Russia RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 60. China RNA Modifying Agents Sales Market Share by Type (2019-2030)

Figure 61. China RNA Modifying Agents Revenue Market Share by Type (2019-2030)

Figure 62. China RNA Modifying Agents Sales Market Share by Application (2019-2030)

Figure 63. China RNA Modifying Agents Revenue Market Share by Application (2019-2030)

Figure 64. Asia RNA Modifying Agents Sales Market Share by Type (2019-2030)

Figure 65. Asia RNA Modifying Agents Revenue Market Share by Type (2019-2030)

Figure 66. Asia RNA Modifying Agents Sales Market Share by Application (2019-2030)

Figure 67. Asia RNA Modifying Agents Revenue Market Share by Application (2019-2030)

Figure 68. Asia RNA Modifying Agents Revenue Share by Region (2019-2030)

Figure 69. Asia RNA Modifying Agents Sales Share by Region (2019-2030)

Figure 70. Japan RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 71. South Korea RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 72. China Taiwan RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 73. Southeast Asia RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 74. India RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 75. Australia RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 76. Middle East, Africa and Latin America RNA Modifying Agents Sales Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America RNA Modifying Agents Revenue Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America RNA Modifying Agents Sales Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America RNA Modifying Agents Revenue Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America RNA Modifying Agents Revenue Share by Country (2019-2030)

Figure 81. Middle East, Africa and Latin America RNA Modifying Agents Sales Share by Country (2019-2030)

Figure 82. Brazil RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 83. Mexico RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 84. Turkey RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 85. Israel RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 86. GCC Countries RNA Modifying Agents Revenue (2019-2030) & (US$ Million)

Figure 87. RNA Modifying Agents Value Chain

Figure 88. RNA Modifying Agents Production Process

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed